MAIN ALAN J 4
4 · LEXICON PHARMACEUTICALS, INC. · Filed Feb 29, 2024
Insider Transaction Report
Form 4
MAIN ALAN J
EVP, Pharmaceutical Research
Transactions
- Exercise/Conversion
Common Stock
2024-02-28+8,977→ 221,563 total - Exercise/Conversion
Common Stock
2024-02-28+25,666→ 247,229 total - Exercise/Conversion
Restricted Stock Units
2024-02-28−25,666→ 25,667 total→ Common Stock (25,666 underlying) - Tax Payment
Common Stock
2024-02-28$2.62/sh−24,408$63,949→ 255,724 total - Exercise/Conversion
Common Stock
2024-02-28+32,903→ 280,132 total - Exercise/Conversion
Restricted Stock Units
2024-02-28−8,977→ 0 total→ Common Stock (8,977 underlying) - Exercise/Conversion
Restricted Stock Units
2024-02-28−32,903→ 65,807 total→ Common Stock (32,903 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
- [F3]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.